O-RAN ALLIANCE Broadens Its Industry Collaboration With ETSI, Announces Its 3rd Whitepaper, and 4th Release of Open Software
16.8.2021 15:58:00 EEST | Business Wire | Press release
The O-RAN ALLIANCE welcomes 1&1 as its newest operator member, extending the world-wide community of 30 mobile network operators committed to deployment of open and intelligent Radio Access Networks (RAN).
The Third O-RAN Whitepaper Focuses on O-RAN Minimum Viable Plan and Acceleration towards Commercialization
Published on June 29, 2021, the whitepaper describes key areas to accelerate and enable the introduction of the rich capabilities of O-RAN Architecture in commercial networks. It also outlines a minimum viable set of end-to-end specifications for selected use cases to deploy a secure, multi-vendor interoperable network. The full whitepaper is available at our website.
O-RAN ALLIANCE Sets Cooperation with ETSI and TSDSI
To ensure compatibility and to avoid duplication of work, the O-RAN ALLIANCE’s specification effort builds on common standards and values alignment with other industry bodies.
On May 27, 2021, the O-RAN ALLIANCE signed a cooperation agreement with the European Telecommunications Standards Institute (ETSI). O-RAN ALLIANCE shares with ETSI a common objective to perform and promote regional and international standardization for 3GPP based technologies.
The O-RAN ALLIANCE also signed a Memorandum of Understanding with the Telecommunications Standards Development Society, India (TSDSI). It expresses mutual interest in cooperation to grow open interfaces and the open RAN ecosystem in the India subcontinent region.
New Open Test and Integration Centers (OTIC)
On June 28, 2021, the O-RAN ALLIANCE approved three new OTICs:
- European OTIC in Madrid hosted by Telefonica
- European OTIC in Paris hosted by Orange
- Auray OTIC and Security Lab (Taiwan) hosted by Auray Technology
The newly approved OTICs are widening the collaborative, open, and impartial working environment to ensure consistency and quality of testing of O-RAN products and solutions. See the full list of approved OTICs at our website.
New Standards Collaboration Copyright License (SCCL) to Simplify the Open Source Development
O-RAN ALLIANCE has introduced a new Standards Collaboration Copyright License (SCCL). The SCCL has been developed to simplify the process of producing open source SW based on standards, by defining a license that will make it easier for the open source community to use code-like sections of O-RAN specifications in their implementations.
“We believe that open source will play an important role in enabling open implementations, even if an operator never deploys stand-alone open source code in its network,” said Alex Jinsung Choi, Chief Operating Officer of the O-RAN ALLIANCE and SVP of Strategy and Technology Innovation, Deutsche Telekom. “The open source can help suppliers build their commercial implementations, and perhaps most importantly, it can also make it easier to achieve cross-vendor integration and interoperability between open RAN components by providing a reference implementation.”
The June 2021 O-RAN ALLIANCE Industry Summit Available for Replay
The O-RAN ALLIANCE Industry Summit on June 29 provided valuable insights on the latest O-RAN development, especially in terms of commercialization, security and performance. The 90-minute event is available for replay on demand at our website.
4th Release of Open Software for the RAN Developed by the O-RAN Software Community
The O-RAN Software Community (OSC or O-RAN SC) was formed in partnership with the Linux Foundation in April 2019, to support software development of open RAN solutions available to everyone.
The “D” release delivers major enhancements including support for closed-loop processing use cases, continued evolution of Non-Real-Time RAN Intelligent Control (Non-RT RIC) platform, new and enhanced xApps for the Near-Real-Time Radio Intelligent Controller (Near-RT RIC), as well as new performance monitoring and alarm support.
To deep-dive into the D release and to get the open software, please visit the O-RAN Software Community website.
"With the joint efforts from the mobile carriers, traditional vendors, and more technology partners onboard, the 4th release is the first try to get the full O-RAN software stack working, and in addition we can now declare it is a smart RAN," said Chih-Lin I, the Co-chair of O-RAN Technical Steering Committee. "We are glad to see major accomplishments in the D release, and that our lab now delivers a reliable environment for the software community to continue new feature implementation and integration test verification."
"Ericsson continues to be very active in O-RAN ALLIANCE making contributions to specifications and O-RAN architecture evolution,” said Per Beming, Head of Standard and Industry Initiatives at Ericsson. "In the OSC D release, Ericsson has continued as the key contributor to the Non-RT RIC project by further evolving support for the A1 interface, in addition to laying the foundations for Non-RT RIC automation applications and the R1 interface. Delivering a framework which supports rApp development is a key aspect of intent based management with the A1 interface, enabling more fine-grained intelligent control and optimization decisions.”
“We are excited to extend our contributions to another Linux Foundation project. Our most recent contributions towards the OAM component in the D-release of O-RAN SC demonstrate PANTHEON.tech's commitment to help our customers with the evolution and adoption of open-source projects," said Miroslav Miklus, Chief Product Officer at PANTHEON.tech.
”Making the RAN intelligent and context-aware is critically important for network optimization and automation. The focus of Samsung's O-RAN SC contribution has been towards enhancing the A1-Enrichment Information (A1-EI) & xAPP Framework. Overall, we believe that strengthening the O-RAN AI/ML Framework will play a big role in making operators achieve proactive closed-loop optimization and automation of RAN operations," said Dr. Sunghyun Choi, Corporate SVP and Head of Advanced Communications Research Center of Samsung Research, Samsung Electronics.
“Xoriant has participated in the O-RAN Software Community by contributing code to O1/VES interface of SMO,” said Girish Gaitonde, CEO of Xoriant. “We contributed to the initial implementation of the O-RAN O1/VES interface for OSC, with the idea to enable a close loop automation use-case between SMO and the other network functions such as O-DU, O-RU, O-CU and the Near RT-RIC.”
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of 315 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN standards will enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks will at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information please visit www.o-ran.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210816005392/en/
Contact information
O-RAN ALLIANCE PR Contact
Zbynek Dalecky
pr@o-ran.org
O-RAN ALLIANCE e.V.
Buschkauler Weg 27
53347 Alfter/Germany
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
